Chao Wang, PhD
I first engaged in Alzheimer’s disease (AD)-related research during my PhD training in the Medical Biochemistry and Biophysics Department at the Umea University, Sweden. My PhD research mainly focused on the role of the pro-inflammatory protein S100A9 in the amyloid-neuroinflammatory cascade in AD and traumatic brain injury. Since 2017, I have been pursuing my post-doctoral training with Dr. David Holtzman, MD, in the Department of Neurology at Washington University in St. Louis. My research now is focused on understanding how LDLR affects apoE4-related tau pathology and brain dysfunction.